Aspirin to prevent recurrent pancreatitis
Part of Digestive system clinical trials.
This trial tests if taking aspirin daily can prevent repeated attacks of acute pancreatitis. It's for people who have had at least two episodes of pancreatitis in the past year that were not caused by a medical procedure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had at least 2 episodes of acute pancreatitis in the last year
- Your pancreatitis episodes were not caused by a medical procedure like ERCP or surgery
- You are not allergic to aspirin or other NSAID pain relievers
- You do not currently take aspirin or another NSAID more than 3 times a week
- You do not have a current or recent stomach ulcer or bleeding, or serious liver or kidney disease
- You do not have gallstones, very high triglycerides, or severe alcohol use disorder
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if pirfenidone, an anti-scarring drug, can reduce the number of repeat episodes of acute pancreatitis. You may be eligible if you've had two or more pancreatitis attacks at least three months apart and are not having an active attack right now.
This trial is studying whether stopping alcohol and quitting smoking can help keep acute pancreatitis from returning. It’s for people whose pancreatitis happened because of alcohol, and who smoke every day.
This trial follows the natural course of recurrent acute pancreatitis and tests how well treatments work for it.
This study tests whether a GLP-1 medication (a drug that helps control blood sugar and triglycerides) can prevent pancreatitis from coming back in people who had a severe attack caused by very high triglyceride levels. If it works, it could help you avoid future painful attacks.
This study tests whether a procedure called ERCP can help find and treat the cause of recurrent pancreatitis that remains unexplained after standard tests.
This early-phase study tests whether simvastatin can improve patient-reported symptoms in people with recurrent acute or chronic pancreatitis. It’s meant to see if the medicine is tolerable and helps with how you feel day to day.
Hear when a new Recurrent Acute Pancreatitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.